SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent - BioSpace
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent BioSpace
Published: Jul 23, 2019. North America, Europe and Japan trial seeks approval for the US and Japanese markets. TIANJIN, China, July 23, 2019 /PRNewswire/ ...
Comments
Post a Comment